Precigen (NASDAQ:PGEN) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
5
1
0
0
0
Last 30D
2
0
0
0
0
1M Ago
2
0
0
0
0
2M Ago
0
0
0
0
0
3M Ago
1
1
0
0
0
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $8.17, a high estimate of $14.00, and a low estimate of $6.00. This current average has increased by 29.07% from the previous average price target of $6.33.
Investigating Analyst Ratings: An Elaborate Study
The analysis of recent analyst actions sheds light on the perception of Precigen by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst
Analyst Firm
Action Taken
Rating
Current Price Target
Prior Price Target
Swayampakula Ramakanth
HC Wainwright & Co.
Maintains
Buy
$6.00
$6.00
Benjamin Burnett
Stifel
Raises
Buy
$10.00
$7.00
Swayampakula Ramakanth
HC Wainwright & Co.
Maintains
Buy
$6.00
$6.00
Benjamin Burnett
Stifel
Maintains
Buy
$7.00
-
Jason Butler
JMP Securities
Maintains
Market Outperform
$14.00
-
Swayampakula Ramakanth
HC Wainwright & Co.
Maintains
Buy
$6.00
-
Key Insights:
Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Precigen. This information offers a ...Full story available on Benzinga.com
Benzinga
